Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Agilent Ventures is the corporate venture capital arm of Agilent Technologies, focusing on strategic investments in early-stage companies within the life sciences, diagnostics, and applied chemical markets. The group seeks to partner with innovative startups that align with Agilent's core businesses, including analytical instrumentation, clinical diagnostics, and laboratory workflows. By providing capital and access to Agilent's global expertise, the venture unit aims to accelerate the development of breakthrough technologies in genomics, proteomics, and metabolomics. Their portfolio includes a diverse range of companies specializing in advanced imaging, mass spectrometry, and digital health solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Agilent Ventures.